Coinciding with this year’s AASLD Liver Meeting, ProSciento will hold its inaugural NASH Roundtable, a scientific forum bringing together leading scientific and clinical development experts in NASH to advance science, methods and strategies for NASH clinical and pre-clinical development programs. The collaborative, advisory roundtable will also provide the biopharma community ongoing access to a panel of today’s leading experts, representing cross-functional academic and industry expertise in clinical study design, biomarker utilization, and endpoint selection individualized for drug targets and customized to support NASH clinical development programs. The initiative is organized and funded by ProSciento, a clinical research organization (CRO) focused exclusively on NASH, diabetes, obesity, and related metabolic diseases.
For more information, please contact bd@prosciento.com.
